GlassScriptPhysician profile
Nader Sadi
NPI 1831777499
$2,382.65
in general payments reported to CMS, 2019-2025
20 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $233 · 2022: $750 · 2023: $235 · 2024: $634 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,400.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $387.50 | 2022-2025 | Pangea, Fixos, Augment Injectable |
| Medshape, INC. | $332.49 | 2023-2024 | Dynanail Helix, Washer, 15 Mm, Dynanail, Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Zimmer Biomet Holdings, INC. | $294.11 | 2021-2022 | |
| Kerecis Limited | $183.86 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Innovation Technologies INC | $148.18 | 2023 | Irrisept |
| Paratek Pharmaceuticals, INC. | $140.93 | 2024-2025 | Nuzyra |
| Horizon Therapeutics Plc | $126.68 | 2021 | |
| Melinta Therapeutics, LLC | $124.12 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $123.63 | 2025 | Exparel |
| Organogenesis INC. | $121.59 | 2022 | |
| Bioventus LLC | $110.50 | 2024 | Exogen Ultrasound Bone Healing System |
| Acera Surgical, INC. | $81.09 | 2021-2024 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $42.79 | 2025 | Stravix |
| Treace Medical Concepts, INC. | $35.85 | 2025 | |
| Fusion Orthopedics USA, LLC | $33.15 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.02 | 2025 | Krystexxa |
| Paragon 28, INC. | $22.20 | 2025 | Precision Mis Bunion |
| Lightbody Medical Technologies INC | $17.84 | 2025 | |
| Acumed LLC | $16.63 | 2025 | Acumed, Osteomed |
| Polynovo North America LLC | $16.49 | 2025 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nader Sadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.